Akeso (Cayman) Limited announced changes to its board of directors on July 1, 2024. Dr. Xia Yu and Dr. Zhou Yi resigned as executive and non-executive directors, respectively, and were succeeded by Dr. Zhang Peng as executive director, effective from June 30, 2024. Drs. Xia and Zhou confirmed that there were no disagreements with the board and that no notice of resignation was required to be given to the shareholders or the Hong Kong Stock Exchange. The board thanked both Drs. Xia and Zhou for their contributions during their terms. Dr. Zhang Peng, the newly appointed executive director, has about 20 years of experience in the biopharmaceutical industry and has held senior positions in multiple companies, and has received numerous honors. Dr. Zhang's term is three years and he will not receive any remuneration for serving as executive director. The board welcomes Dr. Zhang's appointment.

Akeso (Cayman) Limited announced changes to its board of directors on July 1, 2024. Dr. Xia Yu and Dr. Zhou Yi resigned as executive and non-executive directors, respectively, and were succeeded by Dr. Zhang Peng as executive director, effective from June 30, 2024. Drs. Xia and Zhou confirmed that there were no disagreements with the board and that no notice of resignation was required to be given to the shareholders or the Hong Kong Stock Exchange. The board thanked both Drs. Xia and Zhou for their contributions during their terms. Dr. Zhang Peng, the newly appointed executive director, has about 20 years of experience in the biopharmaceutical industry and has held senior positions in multiple companies, and has received numerous honors. Dr. Zhang's term is three years and he will not receive any remuneration for serving as executive director. The board welcomes Dr. Zhang's appointment.